No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: I'm pretty sure this question has been covered....

I might be wrong....but I think if the placebo arm is performing pretty much the same as the dosed arm, that a reccomendation can come down to halt the trial based on a lack of benefit.  If MAC events are pretty much lock step in both placebo and dosed why continue?

Share
New Message
Please login to post a reply